tradingkey.logo
tradingkey.logo
Search

LENZ Therapeutics Inc

LENZ
Add to Watchlist
3.705USD
-0.055-1.46%
Market hours 09/24, 13:12ET
116.15MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-1.46%

5 Days

-10.51%

1 Month

-20.83%

6 Months

-66.32%

Year to Date

-76.84%

1 Year

-90.86%

Key Figures

3.760Open
4.140High
77.27KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.25%Turnover Ratio
3.760Prev. Close
3.600Low
284.09KTurnover
LossP/E Static
0.53P/B
0.00%Div Yield TTM
-46.01%ROA
50.40052wk High
0.18Volume Ratio
-49.77MNet Profit
31.35MShares
-3.6425EPS TTM
0.66Beta
-49.71%ROE
3.60052wk Low
14.36%Amplitude
94.90%Gross Margin
116.15MMarket Cap
-0.96Reward/Risk
5.16%Risk Rate
More news coming soon, stay tuned...

LENZ Therapeutics Inc's Score

-0.09vs previous score
Forecast8.29
Financial Health7.27
Technical5.23
Valuation Dimensions8.11
Institutional Confidence10.00
Risk Assessment4.17

Media Coverage

Coverage Level

Very Low
Very High
Positive

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
22.000Target Price
+432.69%Upside Space
Current Rating2026-092026-082026-072026-062026-052026-042026-032026-02
Strong Buy33444444
Buy22223333
Hold22110000
Sell00000000
Strong Sell00000000

LENZ Therapeutics Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Strong sell

Summary

Strong sell

Moving Average

Strong sell

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-1.02/-1.07
Revenue / Forecast
5.49M/2.37M

LENZ Therapeutics Inc Profile

SectorBiotechnology & Medical Research
Ticker SymbolLENZ
Number of employees42
Country

Ownership

ShareholdersProportion
RA Capital Management, LP13.33%
Fidelity Management & Research Company LLC11.81%
Alpha Wave Global, LP11.52%
Versant Ventures8.47%
Shareholder TypesProportion
Investment Advisor42.54%
Venture Capital33.60%
Investment Advisor/Hedge Fund21.57%
Hedge Fund14.43%

FAQs

What is the current price of LENZ Therapeutics Inc (LENZ)?

The current price of LENZ Therapeutics Inc (LENZ) is 3.76.

What is the symbol of LENZ Therapeutics Inc?

The ticker symbol of LENZ Therapeutics Inc is LENZ.

What is the 52-week high of LENZ Therapeutics Inc?

The 52-week high of LENZ Therapeutics Inc is 50.40.

What is the 52-week low of LENZ Therapeutics Inc?

The 52-week low of LENZ Therapeutics Inc is 3.73.

What is the market capitalization of LENZ Therapeutics Inc?

The market capitalization of LENZ Therapeutics Inc is 117.88M.

Is LENZ Therapeutics Inc (LENZ) currently rated as Buy, Hold, or Sell?

According to analysts, LENZ Therapeutics Inc (LENZ) has an overall rating of Buy, with a price target of 22.00.

What is the Earnings Per Share (EPS TTM) of LENZ Therapeutics Inc (LENZ)?

The Earnings Per Share (EPS TTM) of LENZ Therapeutics Inc (LENZ) is -3.64.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.